Home/ Supplements/ Omega 3/ Omega 3-6-9 1,200 mg

Omega 3-6-9 1,200 mg

product on market Softgel Capsule LuckyVitamin Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This supplement combines fish oil and borage oil to provide omega-3, 6, and 9 fatty acids. Strong evidence supports the role of omega-3s in cardiovascular health, while research on borage oil for systemic inflammation is more limited. Together, these ingredients support general lipid balance and cellular function.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Omega 3-6-9 1,200 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Softgel(s)
Serving Size
90
Servings
Fat/Fatty Acid
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
25 Calorie(s)
Total Fat
2.5 Gram(s) (3% DV)
Protein
1 Gram(s) (1% DV)
Borage Oil
800 mg
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
800 mg
Market median: 1000.0mg (212 products) 12 studies (A:0, B:3)

Other Ingredients

Gelatin Glycerin Water D-Alpha-Tocopherol
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Qualified Health
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Usage: Take 2 softgels daily with food.

Warnings & Precautions

Not manufactured with yeast, wheat, gluten, milk, egg or shellfish ingredients. Produced in a GMP facility that processes other ingredients containing these allergens.

Caution: For adults only.

Consult physician if pregnant/nursing, taking medication, or have a medical condition.

Keep out of reach of children.

Contains fish (anchovies, sardines, tuna).

Formulation Notes

Supportive but not conclusive research shows that consumption of EPA and DHA omega-3 fatty acids may reduce the risk of coronary heart disease. This product is a blend of fish, borage and flax seed oils. This combination of well-known nutritional oils has a unique balance of omega-3 and omega-6 essential fatty acids plus omega-9, a non-essential, but useful fatty acid. The omega-3s, alpha linolenic acid, EPA and DHA, and the omega-6, GLA, are necessary for the maintenance of healthy skin, normal immune system balance, and proper nervous system function.

The fish oil concentrate used in this softgel is manufactured under strict quality control standards. It is tested to be free of potentially harmful levels of contaminants (i.e. mercury, heavy metals, PCBs, dioxins, and other contaminants).

It is tested to be free of potentially harmful levels of contaminants (i.e. mercury, heavy metals, PCBs, dioxins, and other contaminants).

Not manufactured with yeast, wheat, gluten, milk, egg or shellfish ingredients.

Produced in a GMP facility that processes other ingredients containing these allergens.

Natural color variation may occur in this product.

Cardiovascular health

From borage, flax seed & fish oils

Fish oil is product of Peru, Morocco, Thailand, China.

Non-GMO

Additional Information

Store in a cool, dry place after opening.

1 year happiness guarantee

Naturally occurring fatty acids (example) per serving Omega-3 fatty acids 604 mg (EPA: 126 mg, DHA: 78 mg) Omega-6 fatty acids 539 mg (GLA: 160 mg) Omega-9 fatty acids 225 mg Subject to natural variability

Guaranteed Quality & Potency

Metadata

Product Details

UPC / SKU8 10026 42229 4
DSLD Entry Date2023-03-22
Product TypeFat/Fatty Acid
FormSoftgel Capsule
DSLD ID283256
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.